How We Escalate Vasopressor and Corticosteroid Therapy in Patients With Septic Shock

Chest. 2023 Mar;163(3):567-574. doi: 10.1016/j.chest.2022.09.019. Epub 2022 Sep 23.

Abstract

Septic shock is defined by the need for vasopressor agents to correct hypotension and lactic acidosis resulting from infection, with 30%-40% case fatality rates. The care of patients with worsening septic shock involves multiple treatment decisions involving vasopressor choices and adjunctive treatments. In this edition of "How I Do It", we provide a case-based discussion of common clinical decisions regarding choice of first-line vasopressor, BP targets, route of vasopressor delivery, use of secondary vasopressors, and adjunctive medications. We also consider diagnostic approaches, treatment, and monitoring strategies for the patient with worsening shock, as well as approaches to difficult weaning of vasopressors.

Keywords: central venous catheters; peripheral IV catheters; septic shock; steroids; vasoconstrictor agents.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Causality
  • Humans
  • Hypotension* / drug therapy
  • Shock, Septic* / therapy
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Vasoconstrictor Agents
  • Adrenal Cortex Hormones